EP2915525
Töflur, sem ekki er hægt að misnota, til notkunar undir tungu sem innihalda búprenórfín og naloxón
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.9.2012EP published:
11.8.2021EP application number:
15156024.0
EP translation filed:
14.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
17.9.2032Expiry date:
17.9.2026Next due date:
30.9.2026
Title:
Sublingual abuse-resistant tablets comprising buprenorphine and naloxone
Timeline
Today
18.9.2012EP application
11.8.2021EP Publication
14.9.2021Translation submitted
15.10.2021Registration published
17.9.2026Expires
Owner
Name:
Orexo ABAddress:
Box 303, 751 05 Uppsala, SE
Inventor
Name:
Fischer, AndreasAddress:
SE-751 05 Uppsala, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161536180 PDate:
19.9.2011Country:
US
Classification
Categories:
A61K 9/00, A61K 31/485, A61K 9/20, A61K 31/4748, A61P 25/04, A61P 25/30, A61P 25/36
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 27.9.2021
Expires: 17.9.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 27.9.2022
Expires: 17.9.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 30.6.2023
Expires: 17.9.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 24.9.2024
Expires: 17.9.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.8.2025
Expires: 17.9.2026
Payer: iPify